LONG-TERM MORTALITY FOLLOWING CORONARY ARTERY BYPASS GRAFT SURGERY AND STENTING WITH DRUG-ELUTING STENTS  by Wu, Chuntao et al.
Chronic CAD/Stable Ischemic Heart Disease
E1377
JACC March 27, 2012
Volume 59, Issue 13
LONG-TERM MORTALITY FOLLOWING CORONARY ARTERY BYPASS GRAFT SURGERY AND STENTING 
WITH DRUG-ELUTING STENTS
ACC Oral Contributions
McCormick Place North, N227b
Saturday, March 24, 2012, 9:00 a.m.-9:15 a.m.
Session Title: Sex, Scoring, Sadness, Statins, Stents and Surgery
Abstract Category: 3. Chronic CAD/Stable Ischemic Heart Disease: Therapy
Presentation Number: 910-7
Authors: Chuntao Wu, Songyang Zhao, Fabian T. Camacho, Edward Hannan, Penn State Hershey College of Medicine, Hershey, PA, USA, University at 
Albany School of Public Health, State University of New York, Rensselar, NY, USA
Background: There are limited data on the difference in long-term survival between coronary artery bypass graft (CABG) surgery and stenting with 
drug-eluting stents (DES) in real-world practice. Earlier, we compared the difference in 18-month survival between the 2 procedures. In this study, we 
examined the difference in 5-year mortality.
Methods: The New York State’s Cardiac Surgery Reporting System and Percutaneous Coronary Intervention Reporting System were used to identify 
13,296 CABG patients and 20,181 DES patients who had mutlivessel coronary disease and underwent procedures between October 1, 2003 and 
December 31, 2005, and the National Death Index was used to determine the vital status of these patients until the end of 2008. The CABG patients 
were then matched on a 1:1 ratio on the number of diseased vessels, the involvement diseased proximal left anterior descending (LAD) artery, and 
the propensity of receiving CABG surgery (instead of stenting). Kaplan-Meier survival analysis and Cox proportional hazards regression modeling were 
conducted to compare the risk of 5-year mortality between the two procedures.
Results: The propensity matching yielded 8,070 pairs of CABG and stent patients. The standardized differences in the distributions of all baseline 
risk factors were less than 3%, which indicates that all risk factors were well balanced. The 5-year Kaplan-Meier survival rates were 80.2% for CABG 
surgery and 72.9% for stenting (hazard ratio = 0.74, 95% confidence interval: 0.68 to 0.81, P<0.001). The hazard ratios were 0.65 (P<0.001) for 
patients with 3-vessel disease with proximal LAD artery disease, 0.76 (P<0.001) for 3-vessel disease with nonproxmial LAD artery disease, 0.67 
(P<0.001) for patients with 2-vessel disease with proximal LAD artery disease, and 0.70 (P=0.005) for 2-vessel disease with nonproxmial LAD 
artery disease. There was no difference in risk of mortality between CABG surgery and stenting in patients with 2 diseased vessels without LAD artery 
disease (hazard ratio = 0.95, P=0.72). 
Conclusion: In mutlivessel coronary disease, CABG surgery is associated with lower risk of mortality in all patients except in patients without LAD 
artery disease.
